Verdence Capital Advisors LLC Takes $298,000 Position in Amdocs Limited (NASDAQ:DOX)

Verdence Capital Advisors LLC purchased a new stake in shares of Amdocs Limited (NASDAQ:DOXFree Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,395 shares of the technology company’s stock, valued at approximately $298,000.

Several other hedge funds also recently modified their holdings of DOX. Operose Advisors LLC increased its position in shares of Amdocs by 148.0% during the 3rd quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after purchasing an additional 185 shares during the period. Oakworth Capital Inc. acquired a new position in shares of Amdocs during the 4th quarter valued at $26,000. VisionPoint Advisory Group LLC grew its holdings in shares of Amdocs by 77.7% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company’s stock worth $42,000 after acquiring an additional 220 shares during the last quarter. Allworth Financial LP grew its holdings in shares of Amdocs by 16,840.0% in the 3rd quarter. Allworth Financial LP now owns 847 shares of the technology company’s stock worth $72,000 after acquiring an additional 842 shares during the last quarter. Finally, Quent Capital LLC grew its holdings in shares of Amdocs by 27.3% in the 4th quarter. Quent Capital LLC now owns 1,148 shares of the technology company’s stock worth $101,000 after acquiring an additional 246 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Citigroup lifted their target price on Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Barclays lifted their target price on Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, February 8th. Finally, StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $108.60.

Get Our Latest Report on DOX

Amdocs Stock Performance

Shares of DOX stock opened at $86.57 on Wednesday. Amdocs Limited has a 1-year low of $78.38 and a 1-year high of $99.75. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $10.18 billion, a price-to-earnings ratio of 18.54, a P/E/G ratio of 1.40 and a beta of 0.69. The stock’s fifty day simple moving average is $89.93 and its 200-day simple moving average is $87.33.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.16. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter in the previous year, the company posted $1.33 earnings per share. Amdocs’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, sell-side analysts predict that Amdocs Limited will post 5.87 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be given a dividend of $0.479 per share. This is a boost from Amdocs’s previous quarterly dividend of $0.44. The ex-dividend date is Wednesday, March 27th. This represents a $1.92 dividend on an annualized basis and a yield of 2.21%. Amdocs’s dividend payout ratio (DPR) is presently 40.90%.

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.